Key result
Insulin therapy resulted in clinical recovery and reduction of serum triglyceride levels to less than 500 mg/dL in 33 of 34 patients with hypertriglyceridemic pancreatitis.
Why the study?
Does insulin therapy safely reduce triglyceride levels and improve clinical outcomes in patients with hypertriglyceridemic pancreatitis?
Does insulin therapy safely reduce triglyceride levels and improve clinical outcomes in patients with hypertriglyceridemic pancreatitis?
Insulin therapy is a safe, feasible, and effective alternative for managing hypertriglyceridemic pancreatitis, particularly in settings where plasmapheresis is unavailable.
No takes yet. Share an insight, caveat, or question.
May support insulin as alternative when plasmapheresis unavailable; leaves open need for randomized confirmation.
Inayat et al. (2018) conducted a review in Hypertriglyceridemic Pancreatitis (n=34). Insulin therapy was evaluated on Clinical recovery and reduction in serum triglyceride levels. Insulin therapy resulted in clinical recovery and reduction of serum triglyceride levels to less than 500 mg/dL in 33 of 34 patients with hypertriglyceridemic pancreatitis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: